首页> 外文OA文献 >Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine‐based therapy with or without bevacizumab

【2h】

Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine‐based therapy with or without bevacizumab

机译：基线血清白蛋白是用贝伐单抗治疗的晚期胰腺癌患者的预测生物标志物：对有或没有贝伐单抗的吉西他滨治疗的7项前瞻性试验的汇总分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pant Shubham; Martin Ludmila K.; Geyer Susan; Wei Lai; Van Loon Katherine; Sommovilla Nilli; Zalupski Mark; Iyer Renuka; Fogelman David; Ko Andrew H.; Bekaii‐saab Tanios;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab [J] . PantS., MartinL.K., GeyerS., Cancer: A Journal of the American Cancer Society . 2014,第12期

机译：基线血清白蛋白是贝伐单抗治疗的晚期胰腺癌患者的预测生物标志物：对吉西他滨为基础的有或无贝伐单抗的治疗的7项前瞻性试验的汇总分析
2. Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab [J] . Pant Shubham, Martin Ludmila K., Geyer Susan, American Journal of Clinical Oncology: Cancer Clinical Trials . 2016,第6期

机译：与治疗相关的高血压作为贝伐单抗治疗晚期胰腺癌疗效的药效生物标志物基于吉西他滨的贝伐单抗治疗的4个前瞻性试验的汇总分析
3. Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab. [J] . Katherine Van Loon, Anne M Espinoza, David R Fogelman, Pancreas . 2014,第3期

机译：联合化疗是否应作为晚期胰腺癌临床试验的骨干？含吉西他滨的双重药物加贝伐单抗II期临床试验的汇总分析。
4. Applying Quantitative Adiposity Feature Analysis Models to Predict Benefit of Bevacizumab-based Chemotherapy in Ovarian Cancer Patients [C] . Yunzhi Wang, Yuchen Qiu, Theresa Thai, Conference on medical imaging . 2016

机译：应用定量肥胖特征分析模型预测基于贝伐单抗的卵巢癌化疗获益
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Baseline Serum Albumin Is a Predictive Biomarker for Patients With Advanced Pancreatic Cancer Treated With Bevacizumab [O] . Shubham Pant, Ludmila K. Martin, Susan Geyer, -1

机译：基线血清白蛋白是贝伐单抗治疗的晚期胰腺癌患者的预测生物标志物
7. Erratum: Pant S, Martin LK, Geyer S, Wei L, Van Loon K, Sommovilla N, Zalupski M, Iyer R, Fogelman D, Ko AH and Bekaii-Saab T. Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled [O] . 2014

机译：呃：Pant S，Martin LK，Geyer S，Wei L，Van Loon K，Sommovilla N，Zalupski M，Iyer R，Fogelman D，KO Ah和Bekaii-Saab T.Sasely血清白蛋白是胰腺晚期胰腺的预测生物标志物用贝伐单抗治疗的癌症：汇集

Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine‐based therapy with or without bevacizumab

著录项

相似文献

相关主题

期刊订阅